429 related articles for article (PubMed ID: 30084070)
1. The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems.
Shin SH; Srivilai J; Ibrahim SA; Strasinger C; Hammell DC; Hassan HE; Stinchcomb AL
AAPS PharmSciTech; 2018 Oct; 19(7):2778-2786. PubMed ID: 30084070
[TBL] [Abstract][Full Text] [Related]
2. On the Road to Development of an in Vitro Permeation Test (IVPT) Model to Compare Heat Effects on Transdermal Delivery Systems: Exploratory Studies with Nicotine and Fentanyl.
Shin SH; Ghosh P; Newman B; Hammell DC; Raney SG; Hassan HE; Stinchcomb AL
Pharm Res; 2017 Sep; 34(9):1817-1830. PubMed ID: 28608140
[TBL] [Abstract][Full Text] [Related]
3. Effects of pressure sensitive adhesives and chemical permeation enhancers on the permeability of fentanyl through excised rat skin.
Mehdizadeh A; Ghahremani MH; Rouini MR; Toliyat T
Acta Pharm; 2006 Jun; 56(2):219-29. PubMed ID: 16613727
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Heat Effects on Fentanyl Transdermal Delivery Systems Using In Vitro Permeation and In Vitro Release Methods.
Zhang Q; Murawsky M; LaCount TD; Hao J; Ghosh P; Raney SG; Kasting GB; Li SK
J Pharm Sci; 2020 Oct; 109(10):3095-3104. PubMed ID: 32702372
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro/in vivo correlations for three fentanyl transdermal delivery systems using in vitro skin permeation testing and human pharmacokinetic studies under the influence of transient heat application.
Shin SH; Yu M; Hammell DC; Ghosh P; Raney SG; Hassan HE; Stinchcomb AL
J Control Release; 2022 Feb; 342():134-147. PubMed ID: 34838928
[TBL] [Abstract][Full Text] [Related]
6. Impact of Different Mixing Methods on the Performance of Suspension-Based Transdermal Delivery Systems.
Bhattaccharjee SA; Kale M; Le N; Banga AK
AAPS PharmSciTech; 2021 May; 22(4):150. PubMed ID: 33973096
[TBL] [Abstract][Full Text] [Related]
7. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of fentanyl from matrix and reservoir systems: effect of heat and compromised skin.
Prodduturi S; Sadrieh N; Wokovich AM; Doub WH; Westenberger BJ; Buhse L
J Pharm Sci; 2010 May; 99(5):2357-66. PubMed ID: 19967778
[TBL] [Abstract][Full Text] [Related]
9. Effect of different enhancers on the transdermal permeation of insulin analog.
Yerramsetty KM; Rachakonda VK; Neely BJ; Madihally SV; Gasem KA
Int J Pharm; 2010 Oct; 398(1-2):83-92. PubMed ID: 20667506
[TBL] [Abstract][Full Text] [Related]
10. Effect of Mild Hyperthermia on Transdermal Absorption of Nicotine from Patches.
Panda A; Sharma PK; Narasimha Murthy S
AAPS PharmSciTech; 2019 Jan; 20(2):77. PubMed ID: 30635802
[TBL] [Abstract][Full Text] [Related]
11. Formulation issues associated with transdermal fentanyl delivery.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
[TBL] [Abstract][Full Text] [Related]
12. Influence of penetration enhancer on drug permeation from volatile formulations.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
[TBL] [Abstract][Full Text] [Related]
13. In vitro-in vivo correlations for nicotine transdermal delivery systems evaluated by both in vitro skin permeation (IVPT) and in vivo serum pharmacokinetics under the influence of transient heat application.
Shin SH; Thomas S; Raney SG; Ghosh P; Hammell DC; El-Kamary SS; Chen WH; Billington MM; Hassan HE; Stinchcomb AL
J Control Release; 2018 Jan; 270():76-88. PubMed ID: 29175139
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the percutaneous penetration of cisplatin: the effect of monoolein and the drug skin penetration pathway.
Simonetti LD; Gelfuso GM; Barbosa JC; Lopez RF
Eur J Pharm Biopharm; 2009 Sep; 73(1):90-4. PubMed ID: 19442727
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery.
Kanikkannan N; Kandimalla K; Lamba SS; Singh M
Curr Med Chem; 2000 Jun; 7(6):593-608. PubMed ID: 10702628
[TBL] [Abstract][Full Text] [Related]
16. Controlled transdermal delivery of fentanyl: characterizations of pressure-sensitive adhesives for matrix patch design.
Roy SD; Gutierrez M; Flynn GL; Cleary GW
J Pharm Sci; 1996 May; 85(5):491-5. PubMed ID: 8742940
[TBL] [Abstract][Full Text] [Related]
17. Generic patches containing fentanyl: In vitro equivalence and abuse deterrent evaluation according to EMA and FDA guidelines.
Padula C; Pescina S; Nicoli S; Santi P
Int J Pharm; 2018 Feb; 537(1-2):57-63. PubMed ID: 29253583
[TBL] [Abstract][Full Text] [Related]
18. The Effect and Mechanism of Transdermal Penetration Enhancement of Fu's Cupping Therapy: New Physical Penetration Technology for Transdermal Administration with Traditional Chinese Medicine (TCM) Characteristics.
Xie WJ; Zhang YP; Xu J; Sun XB; Yang FF
Molecules; 2017 Mar; 22(4):. PubMed ID: 28346390
[TBL] [Abstract][Full Text] [Related]
19. Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch.
Oliveira G; Hadgraft J; Lane ME
Toxicol In Vitro; 2012 Jun; 26(4):645-8. PubMed ID: 22405881
[TBL] [Abstract][Full Text] [Related]
20. Development of matrix patches for transdermal delivery of a highly lipophilic antiestrogen.
Funke AP; Günther C; Müller RH; Lipp R
Drug Dev Ind Pharm; 2003 Aug; 29(7):785-93. PubMed ID: 12906336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
